Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D07001 in Advanced GI and Biliary Tract Cancers
NCT03531320Phase 2Completed
- Sponsor
- InnoPharmax Inc.
- Start
- Aug 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of D07001-F4 in gastrointestinal cancer, biliary tract cancer (BTC), sponsored by InnoPharmax Inc.. Started Aug 2018; status: completed.
02
Drugs
D07001-F4
03
Conditions
gastrointestinal cancerbiliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT03531320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03531320.